Search - tctmd.com

Displaying 1 - 20 of 659

Sort: Relevancy | Date

Presentation Cardiovascular Interventions 2025

Are Bioresorbable Scaffolds Making a Comeback?

Presenter: Ajay Kirtane

November 13, 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

Presentation TCT 2025

TCT 240: Integrated Assessment of Coronary Physiology and Plaque Vulnerability Following Resorption of Magnesium-Resorbable Scaffolds

Presenter: Stefano Galli

October 28, 2025

Presentation TCT 2025

Bioresorbable Scaffolds as a Preferred Treatment for Ruptured Plaques and Younger ACS Patients: Is It Still a Possibility?

Presenter: Maciej Lesiak

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

Dissolving Barriers: Bioresorbable Scaffolds in Action

Presenter: Catherine Popik

October 25, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presenter: Lei Song

October 30, 2024

Presentation TCT 2024

Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

Presenter: Stefano Galli

October 30, 2024

Presentation TCT 2024

Cryotherapy For Vulnerable Plaque Stabilization: Preliminary Report From Polarstar, A First-In-Human Study

Presenter: Frederic Bouisset

October 30, 2024

Presentation TCT 2024

Coronary Bioresorbable Vascular Scaffolds: Any Chance of Resurrection?

Presenter: Grzegorz Kaluza

October 30, 2024

Presentation TCT 2024

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

Presenter: Sahil Parikh

October 30, 2024

Presentation TCT 2024

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

Presenter: Jiasheng Yin

October 27, 2024

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Daily News

FDA Medical Devices Chief Jeff Shuren Announces Retirement

L.A. McKeown

July 24, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

Presentation TCT 2023

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

Presenter: SIMONE FEZZI

October 25, 2023

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

Advertisement

Are Bioresorbable Scaffolds Making a Comeback?

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

TCT 240: Integrated Assessment of Coronary Physiology and Plaque Vulnerability Following Resorption of Magnesium-Resorbable Scaffolds

Bioresorbable Scaffolds as a Preferred Treatment for Ruptured Plaques and Younger ACS Patients: Is It Still a Possibility?

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Dissolving Barriers: Bioresorbable Scaffolds in Action

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Twelve-Month Clinical Outcomes of the Magmaris Resorbable Magnesium Scaffold in Complex Lesions: Insights From the IT-MASTERS Registry

Cryotherapy For Vulnerable Plaque Stabilization: Preliminary Report From Polarstar, A First-In-Human Study

Coronary Bioresorbable Vascular Scaffolds: Any Chance of Resurrection?

Insights and Innovations in Scaffold Technologies for Peripheral Intervention: Bioresorbable and Metal Scaffolds Are The Answer

TCT 363: Five-Year Clinical Outcomes of Patients Treated With the XINSORB Bioresorbable Sirolimus-Eluting Scaffolds

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

FDA Medical Devices Chief Jeff Shuren Announces Retirement

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

TCT 440: Physiological Patterns of Coronary Artery Disease and Percutaneous Coronary Intervention with Bioresorbable Vascular Scaffolds

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content